Tools
Tools
Nightingale, Rebecca, Griffiths, Paul, Mortimer, Kevin 
ORCID: https://orcid.org/0000-0002-8118-8871, Walker, Paul P, Byrne, Tara, Marwood, Kerry, Morrison-Griffiths, Sally, Renwick, Sue, Rylance, Jamie ORCID: https://orcid.org/0000-0002-2323-3611 and Burnhan, Hassan
(2020)
'Exploring perspectives on chronic obstructive pulmonary disease in people who smoke heroin: a qualitative study'. BJGP Open, Vol 4, Issue 3.
|
Text
COPD in Heroin smokers A patient perspective_BJGP_V2.pdf - Accepted Version Available under License Creative Commons Attribution. Download (216kB) | Preview |
|
|
Text
bjgpopen20X101055.full.pdf - Published Version Available under License Creative Commons Attribution. Download (500kB) | Preview |
Abstract
Background
Smoking rather than injecting heroin has become more common over the last twenty years. Although there is an increasing body of evidence describing high levels of COPD in heroin smokers, there is limited evidence documenting the impact this has on this population group.
Aim. We aimed to describe the experiences of heroin smokers with COPD in Liverpool, UK
Design and Setting Participants were purposefully sampled for this qualitative study. Participants included were adults enrolled in an opioid replacement clinic run by Addaction in Liverpool, UK and whom had already engaged with spirometry testing for COPD as part of a previous study
Methods. We preformed semi-structured interviews with participants with spirometrically-confirmed COPD in opioid replacement clinics in Liverpool, UK. Data were analysed using a framework analysis approach.
Results. We invited 16 potential participants of whom 10 agreed to take part and were interviewed. Three themes common to all interviews were identified: functional measures of lung health that impacted on their activities of daily living, inhaler and medication perceptions with erratic use that was not concordant with their prescription, and the impact of difficulties accessing care.
Conclusion. These findings, along with previous studies highlighting the prevalence of COPD in this population, warrant efforts to integrate community COPD and opioid replacement services to improve outcomes for this vulnerable population.
| Item Type: | Article |
|---|---|
| Subjects: | QV Pharmacology > QV 55 Pharmaceutical preparations (General) QV Pharmacology > Central Nervous System Agents. Local Anesthetics > QV 92 Morphine. Morphine derivatives WF Respiratory System > Lungs > WF 600 Lungs WM Psychiatry > WM 100 General works |
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department Clinical Sciences & International Health > International Public Health Department |
| Digital Object Identifer (DOI): | https://doi.org/10.3399/bjgpopen20X101055 |
| Depositing User: | Debbie Jenkins |
| Date Deposited: | 15 Jul 2020 11:21 |
| Last Modified: | 29 Oct 2020 11:21 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/13748 |
Statistics
Actions (login required)
 |
Edit Item |